{"id":51644,"date":"2021-10-18T06:00:19","date_gmt":"2021-10-18T11:00:19","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/?post_type=topics&p=51644"},"modified":"2025-12-23T13:57:28","modified_gmt":"2025-12-23T18:57:28","slug":"interval-cancers","status":"publish","type":"topics","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/interval-cancers\/","title":{"rendered":"Cancers d\u2019intervalle"},"content":{"rendered":"

Pourquoi est-ce important? \u2013<\/strong> Les cancers d\u2019intervalle sont des cancers diagnostiqu\u00e9s apr\u00e8s un test de d\u00e9pistage n\u00e9gatif, mais avant qu\u2019un participant ne revienne au sein du programme pour l\u2019examen de d\u00e9pistage suivant. La surveillance des cancers d\u2019intervalle fournit un m\u00e9canisme d\u2019\u00e9valuation de l\u2019incidence des programmes de d\u00e9pistage sur la mortalit\u00e9 par cancer colorectal, au sein des populations cibles, et constitue une mesure importante de l\u2019efficacit\u00e9 du d\u00e9pistage et du suivi diagnostique1<\/sup>. Dans ce rapport, les cancers d\u2019intervalle contract\u00e9s sont mesur\u00e9s \u00e0 deux moments distincts\u00a0:<\/p>\n

    \n
  1. Apr\u00e8s un test f\u00e9cal ayant donn\u00e9 un r\u00e9sultat n\u00e9gatif<\/li>\n
  2. Apr\u00e8s une coloscopie ayant donn\u00e9 un r\u00e9sultat n\u00e9gatif, effectu\u00e9e \u00e0 la suite d\u2019un test f\u00e9cal ayant donn\u00e9 un r\u00e9sultat positif<\/a><\/li>\n<\/ol>\n

    1. Taux de cancer d\u2019intervalle apr\u00e8s un r\u00e9sultat de test f\u00e9cal n\u00e9gatif<\/h2>\n

    D\u00e9finition de l\u2019indicateur\u00a0:<\/strong> nombre de personnes, sur\u00a01\u00a0000\u00a0personnes ayant obtenu un r\u00e9sultat n\u00e9gatif \u00e0 un test f\u00e9cal, ayant par la suite re\u00e7u un diagnostic de cancer colorectal avant l\u2019examen de d\u00e9pistage suivant planifi\u00e9<\/p>\n

    Calcul de l\u2019indicateur<\/strong><\/p>\n

    Num\u00e9rateur\u00a0: nombre de personnes ayant re\u00e7u un diagnostic de cancer colorectal dans les deux ans apr\u00e8s avoir obtenu un r\u00e9sultat n\u00e9gatif \u00e0 un test f\u00e9cal, au cours de la p\u00e9riode de mesure<\/p>\n

    D\u00e9nominateur\u00a0: nombre de personnes ayant obtenu un r\u00e9sultat n\u00e9gatif \u00e0 un test f\u00e9cal de d\u00e9pistage, au cours de la p\u00e9riode de mesure<\/p>\n

    Comment la p\u00e9riode 2014-2015 se compare-t-elle \u00e0 celle de 2011-2012?<\/strong> Comparativement aux donn\u00e9es du rapport sur le d\u00e9pistage du cancer colorectal pour 2013-2014, o\u00f9 de 0,3 \u00e0 1,9\u00a0cancers d\u2019intervalle ont \u00e9t\u00e9 trouv\u00e9s pour 1\u00a0000\u00a0d\u00e9pistages, deux provinces ou territoires ont connu une augmentation des cancers d\u2018intervalle, et deux ont connu une diminution en 2014-2015.
    \n    <\/a><\/p>\n

    Taux de cancers colorectaux d\u2019intervalle (pour 1\u00a0000), d\u00e9tect\u00e9s dans les\u00a024\u00a0mois ayant suivi des r\u00e9sultats normaux \u00e0 un test f\u00e9cal, chez les personnes \u00e2g\u00e9es de\u00a050 \u00e0\u00a074\u00a0ans, par province et par territoire, pour les tests f\u00e9caux subis en\u00a02014 et en\u00a02015<\/strong><\/h3>\n

    \"diagramme<\/p>\n

    Description textuelle et notes de bas de page<\/a><\/sub><\/p>\n

    Les cancers d\u2019intervalle d\u00e9tect\u00e9s apr\u00e8s un test f\u00e9cal normal variaient de 0,7 % en Saskatchewan \u00e0 3,2 % \u00e0 l\u2019\u00cele-du-Prince-\u00c9douard.
    \n    <\/a><\/p>\n

    2. Taux de cancers colorectaux apr\u00e8s une coloscopie n\u00e9gative effectu\u00e9e \u00e0 la suite d\u2019un test f\u00e9cal positif<\/h2>\n

    D\u00e9finition de l\u2019indicateur<\/strong>\u00a0: nombre de personnes, sur\u00a01\u00a0000\u00a0personnes ayant subi une coloscopie de suivi n\u00e9gative, ayant re\u00e7u un diagnostic de cancer colorectal, entre six mois et trois ans apr\u00e8s<\/p>\n

    Calcul de l\u2019indicateur<\/strong><\/p>\n

    Num\u00e9rateur\u00a0: nombre de personnes ayant re\u00e7u un diagnostic de cancer colorectal dans les\u00a06 \u00e0\u00a036\u00a0mois ayant suivi une coloscopie normale<\/p>\n

    D\u00e9nominateur\u00a0: nombre de personnes ayant obtenu un r\u00e9sultat anormal \u00e0 un test f\u00e9cal de d\u00e9pistage, au cours de la p\u00e9riode de mesure, et des r\u00e9sultats n\u00e9gatifs pour le cancer colorectal \u00e0 une coloscopie de suivi effectu\u00e9 dans un d\u00e9lai de six mois
    \n    <\/a><\/p>\n

    Taux de cancers colorectaux post-colonoscopie (pour 1\u00a0000) d\u00e9tect\u00e9s dans les\u00a06 \u00e0\u00a036\u00a0mois ayant suivi des r\u00e9sultats normaux de coloscopie, chez les personnes \u00e2g\u00e9es de\u00a050 \u00e0\u00a074\u00a0ans, pour la Saskatchewan et l\u2019\u00cele-du-Prince-\u00c9douard, pour les tests f\u00e9caux subis en\u00a02012 et en 2013<\/strong><\/h3>\n

    \"infographie
    \n* Tests f\u00e9caux de 2012-2013, personnes \u00e2g\u00e9es de 50 \u00e0 74 ans, Saskatchewan et \u00cele-du-Prince-\u00c9douard combin\u00e9es.<\/sub><\/p>\n

    Description textuelle et notes de bas de page<\/a><\/sub><\/p>\n

    La Saskatchewan et l\u2019\u00cele-du-Prince-\u00c9douard ont fourni des donn\u00e9es pour cet indicateur; cependant, en raison des petits nombres, les donn\u00e9es de l\u2019\u00cele-du-Prince-\u00c9douard ne peuvent pas \u00eatre d\u00e9clar\u00e9es seules.<\/p>\n

    Pour la Saskatchewan et l\u2019\u00cele-du-Prince-\u00c9douard, il y a eu\u00a03,0\u00a0cancers colorectaux post-colonoscopie pour\u00a01\u00a0000\u00a0coloscopies normales.<\/p>\n

    R\u00e9f\u00e9rence<\/strong><\/sub>
    \n1 \u2013 Garcia, M., Dom\u00e8nech, X., Vidal, C., Torn\u00e9, E., Mil\u00e0, E., Binefa, G. et coll. (2015). Interval cancers in a population-based screening program for colorectal cancer in Catalonia, Spain. Gastroenterol Res Pract<\/em>, 2015:672410, doi\u00a0:\u00a010.1155\/2015\/672410.<\/sub><\/p>\n","protected":false},"excerpt":{"rendered":"

    Pourquoi est-ce important? \u2013 Les cancers d\u2019intervalle sont des cancers diagnostiqu\u00e9s apr\u00e8s un test de d\u00e9pistage n\u00e9gatif, mais avant qu\u2019un participant ne revienne au sein du programme pour l\u2019examen de d\u00e9pistage suivant. La surveillance des cancers d\u2019intervalle fournit un m\u00e9canisme d\u2019\u00e9valuation de l\u2019incidence des programmes de d\u00e9pistage sur la mortalit\u00e9 par cancer colorectal, au sein […]<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":51630,"menu_order":6,"template":"","topics_tags":[],"type-of-care":[],"cancer-continuum":[],"cancer-system-measurement":[],"dbt-cancer-site":[],"dbt-risk-factors":[],"dbt-population-characteristics":[],"class_list":["post-51644","topics","type-topics","status-publish","hentry"],"acf":[],"yoast_head":"\nCanadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/interval-cancers\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cancers d\u2019intervalle - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"Pourquoi est-ce important? \u2013 Les cancers d\u2019intervalle sont des cancers diagnostiqu\u00e9s apr\u00e8s un test de d\u00e9pistage n\u00e9gatif, mais avant qu\u2019un participant ne revienne au sein du programme pour l\u2019examen de d\u00e9pistage suivant. La surveillance des cancers d\u2019intervalle fournit un m\u00e9canisme d\u2019\u00e9valuation de l\u2019incidence des programmes de d\u00e9pistage sur la mortalit\u00e9 par cancer colorectal, au sein […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/interval-cancers\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-23T18:57:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2022\/02\/physical-ferneture-500-700.png\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/interval-cancers\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/interval-cancers\\\/\",\"name\":\"Cancers d\u2019intervalle - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/interval-cancers\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/interval-cancers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/CRC-Graph-17-interval-24-months-FR.jpg\",\"datePublished\":\"2021-10-18T11:00:19+00:00\",\"dateModified\":\"2025-12-23T18:57:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/interval-cancers\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/interval-cancers\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/interval-cancers\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/CRC-Graph-17-interval-24-months-FR.jpg\",\"contentUrl\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/CRC-Graph-17-interval-24-months-FR.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/interval-cancers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Topics\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/topics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Surveillance et \u00e9valuation des indicateurs de la qualit\u00e9 du d\u00e9pistage du cancer colorectal\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Indicateurs\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Cancers d\u2019intervalle\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/interval-cancers\/","og_locale":"fr_FR","og_type":"article","og_title":"Cancers d\u2019intervalle - Canadian Partnership Against Cancer","og_description":"Pourquoi est-ce important? \u2013 Les cancers d\u2019intervalle sont des cancers diagnostiqu\u00e9s apr\u00e8s un test de d\u00e9pistage n\u00e9gatif, mais avant qu\u2019un participant ne revienne au sein du programme pour l\u2019examen de d\u00e9pistage suivant. La surveillance des cancers d\u2019intervalle fournit un m\u00e9canisme d\u2019\u00e9valuation de l\u2019incidence des programmes de d\u00e9pistage sur la mortalit\u00e9 par cancer colorectal, au sein […]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/interval-cancers\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2025-12-23T18:57:28+00:00","og_image":[{"width":500,"height":700,"url":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2022\/02\/physical-ferneture-500-700.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/interval-cancers\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/interval-cancers\/","name":"Cancers d\u2019intervalle - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/interval-cancers\/#primaryimage"},"image":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/interval-cancers\/#primaryimage"},"thumbnailUrl":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2021\/09\/CRC-Graph-17-interval-24-months-FR.jpg","datePublished":"2021-10-18T11:00:19+00:00","dateModified":"2025-12-23T18:57:28+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/interval-cancers\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/interval-cancers\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/interval-cancers\/#primaryimage","url":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2021\/09\/CRC-Graph-17-interval-24-months-FR.jpg","contentUrl":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2021\/09\/CRC-Graph-17-interval-24-months-FR.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/interval-cancers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Topics","item":"https:\/\/www.partnershipagainstcancer.ca\/topics\/"},{"@type":"ListItem","position":2,"name":"Surveillance et \u00e9valuation des indicateurs de la qualit\u00e9 du d\u00e9pistage du cancer colorectal","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/"},{"@type":"ListItem","position":3,"name":"Indicateurs","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/"},{"@type":"ListItem","position":4,"name":"Cancers d\u2019intervalle"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/51644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/topics"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"up":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/51630"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=51644"}],"wp:term":[{"taxonomy":"topics_tags","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics_tags?post=51644"},{"taxonomy":"type-of-care","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/type-of-care?post=51644"},{"taxonomy":"cancer-continuum","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-continuum?post=51644"},{"taxonomy":"cancer-system-measurement","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-system-measurement?post=51644"},{"taxonomy":"dbt-cancer-site","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-cancer-site?post=51644"},{"taxonomy":"dbt-risk-factors","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-risk-factors?post=51644"},{"taxonomy":"dbt-population-characteristics","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-population-characteristics?post=51644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}